Projects in Knowledge Continuing Education
About Projects In Knowledge, Inc.
The purpose of our healthcare education program is to:
- Increase the clinical skills and knowledge base of clinicians in practice in the US and abroad
- Enhance clinicians' capacity to treat disease and promote health among their patients and in their communities
- Provide a forum in which clinicians may engage colleagues from diverse medical communities in the US and abroad through collaborative projects
- Foster interaction among clinical professionals from different disciplines to forge solutions to shared challenges
- Offer clinicians effective ways to address the demand for quality and accountability
|
|
hematology, continuing medical education, blood disease, hematopathologist, oncology, hemphilia, blood disorder cme, blood transfusion, stem cell transplant
|
|
What is Hematology?
Hematology, is the branch of internal medicine, physiology, pathology, clinical laboratory work, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The laboratory work that goes into the study of blood is frequently performed by a medical technologist. Hematologists physicians also very frequently do further study in oncology - the medical treatment of cancer.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results. In some institutions, hematologists also manage the hematology laboratory.
Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists. Hematologists and hematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Hematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology.
Hematologists may specialize further or have special interests, for example in:
- treating bleeding disorders such as hemophilia and idiopathic thrombocytopenic purpura
- treating hematological malignacies such as lymphoma and leukemia
- treating hemoglobinopathies
- in the science of blood transfusion and the work of a blood bank
- in bone marrow and stem cell transplantation
Only some blood disorders can be cured.
|
American Society of Hematology
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. |
Hematology Continuing Education on CESearchEngine
Find Hematology related continuing education activities on CESearchEngine.com. Research the leading providers on diabetic CE,CME,CPE,CNE. Thousands of Activities. Unlimited Potential. |
 |
|
 |
Anemia
Provided by: The Ohio State University Medical Center
Upon completion of this educational activity,the participant will be able to: 1.) Recognize how to classify anemias. 2.) Review the use of the CBC in the initial evaluation of anemia and subsequent appropriate lab tests.... |
 |
Current Strategies for the Surgical Management of Patients With Congenital Bleeding Disorders
Provided by: Blood CME Center
Experts in bleeding disorders, Victor S. Blanchette, MD, FRCP, Head of the Division of Hematology/Oncology at the Hospital for Sick Children; Steven W. Pipe, MD, Associate Professor of Pediatrics and Pathology at C. S. Mott Children’s Hospital, University of Michigan; and Meera B. Chitlur, MD, Assistant Professor, Division of Pediatric Hematology... |
 |
Understanding Sickle Cell Disease
Provided by: CMElectures
Gaye Riddick-Burden, CRNP, BC, is a nurse practitioner at Thomas Jefferson University Hospital in Philadelphia, and is responsible for the day-to-day operations of the Sickle Cell Day Unit. Samir K. Ballas, MD, is professor of medicine and pediatrics at Thomas Jefferson University, director of the Sickle Cell Center at Jefferson and director of the... |
 |
PAX5 Expression in Nonhematopoietic Tissues: Reappraisal of Previous Studies
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* discuss the use of the clone 24 anti-PAX5 monoclonal antibody.
* list the tumor types in which PAX5 expression has been confirmed.
* describe the major roles of PAX5 in development.
... |
 |
Refining Practice Management for Optimal Outcomes in Chronic Myeloid Leukemia: Determining the Optimal Strategy
Provided by: ASiM
The introduction of tyrosine kinase inhibitors (TKI) has transformed clinical management of chronic myeloid leukemia (CML). Although most patients with CML who are receiving TKI therapy achieve clinically significant hematologic, cytogenetic, and molecular responses, the durability of these responses is limited by the development of mutation-induce... |
 |
Relapsed/Refractory Myeloma: Addressing the Challenge in 2011
Sergio A. Giralt, MD
Provided by: MediCom Worldwide, Inc.
Program Overview
Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to destruction of bone as well as marrow failure. The introduction of novel agents like bortezomib, lenalidomide, and thalidomide have increased life expectancy and quality of life for patients; however, multiple myeloma is currently a... |
 |
Hematology/Oncology
Provided by: Temple University School of Medicine
Educational Objectives:
At the conclusion of the course, participants should be able to:
* Improve the diagnosis and treatment of common family practice problems
* Apply traditional modes of diagnosis and management more effectively
* Apply information to commonly asked questions in office practice
* Increase proficiency an... |
 |
Clinical Challenges in the Diagnosis and Management of Anemia
Provided by: Harvard Medical School
Anemia represents a common problem encountered in daily clinical practice world wide. Hence, a structured approach to evaluating anemia is highly relevant in primary care. Multi-channel automated analyzers have revolutionized the work of performing complete blood counts (CBCs). However, when interpreting results, clinicians must be aware of limitat... |
 |
Anemia Is not a Normal Consequence of Aging: Determing the Etiologic Cause and Optimal Treatment of Geriatric Anemia
Provided by: Primary Issues
Program Overview
Anemia is often considered a normal consequence of aging, but is neither normal nor harmless and may have far-reaching effects. While two-thirds of geriatric anemia cases are caused by nutritional deficiency or by chronic disease, the cause is unidentified in up to one-third of cases. Unidentified anemia may be the result of an oc... |
 |
Bloodborne Pathogen Management
Provided by: ATrain Education Inc.
When you finish this course, you will be able to:
* Explain the importance of bloodborne pathogens in the transmission of chronic and life-threatening diseases.
* Outline the actions employers are required to take to protect their employees from bloodborne pathogens.
* Describe the safe handling and disposal of sharps.
* Review the selection an... |
 |
Risk of Hemolytic Transfusion Reactions Following Emergency-Release RBC Transfusion
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* identify indications for emergency-release RBC transfusion.
* identify the risks of emergency-release RBC transfusion.
* recognize and diagnose hemolytic transfusion reactions.... |
 |
Applying Lean/Toyota Production System Principles to Improve Phlebotomy Patient Satisfaction and Workflow
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* describe Lean/Toyota production system principles.
* apply Lean principles to the clinical laboratory.
* discuss how to conduct and monitor Lean process improvement.... |
 |
Communicable Disease Testing of Blood Donors
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* list the communicable diseases and define the regulatory authority under which allogeneic blood donations must be tested.
* list the communicable diseases and define the regulatory authority under which autologous blood donations must be tested.
* define the risk versus benefit of s... |
 |
Controversies in the Management of Intracerebral Hematomas
Provided by: American Association of Neurological Surgeons
After completing this educational activity, participants should be able to:
* Discuss the management of intracerebral hemorrhage according to current clinical evidence
* Discuss rationale for current clinical studies
* Discuss evidence based medicine in the management of a patient with intracerebral hemorrhage
... |
 |
Identifying Injuries Associated With Airbag Deployment.Hydrops Fetalis Due to Hemoglobin Barts. Check Sample Forensic Pathology 1010-CME
Provided by: American Society for Clinical Pathology
Upon completion of this activity, you will be able to:
* identify the molecular hallmarks of ... |
 |
Prophylaxis in Hemophilia Patients Without Inhibitors and Its Impact on Inhibitor Development
Provided by: Blood CME Center
Prophylaxis is currently considered the optimal treatment for hemophilia management. However, the treatment poses a risk for inhibitor formation, with the highest risk being present during the first 20 exposure days. In this learning activity, Leonard A. Valentino, MD, reviews emerging trends and issues relevant to the treatment of hemophilia patie... |
 |
Microtubule-Targeting Agents: Old, New, and Emerging Roles
Provided by: myCME.com
An update on evolving developments related to microtubule-inhibiting agents and their role in the treatment of women with metastatic or locally advanced breast cancer. Highlights include: an examination of the rationale for microtubule inhibition, including treatment challenges in resistant or refractory breast cancer; a discussion of the clinical ... |
 |
Clinical Insights: Managing Bone Complications in Multiple Myeloma
Provided by: Blood CME Center
Multiple myeloma patients can develop painful bone lesions, and despite their treatment, most lesions fail to heal completely. In this podcast learning activity, Adam D. Cohen, MD, discusses the available diagnostic imaging modalities used in the detection and management of bone disease in multiple myeloma patients, and examines the clinical practi... |
 |
VISICU Critical Care Review -August 2010
Provided by: American Board of Quality Assurance And Utilization Review Physicians
Course Description & Objectives
* List the laboratory tests that are elevated in patients with CAP and positive blood cultures
* Describe the laboratory test with the highest degree of accuracy in predicting CAP patients who are bacteremic
* Compare the effect of IV ibuprofen compared to placebo on reduction of fever defined as... |
 |
Bloodborne Pathogens
Provided by: Wild Iris Medical Education
Upon completion of this course, you will be able to:
* List the basic components of OSHA's bloodborne pathogens standard.
* Describe two common bloodborne diseases and their modes of transmission.
* Explain the purpose of the hepatitis B vaccine.
* Identify several types of personal protective equipment (PPE), work practices, and engineering ... |
 |
Code Sepsis: Clinical Microbiology's Role in the Diagnosis of Bloodstream Infections and Sepsis
Provided by: American Society for Clinical Pathology
Upon completion of this program, you will be able to:
* Explain the medical and operational impact of bloodstream infections and sepsis
* Delineate the limitations of blood culture practices
* Describe the rapid methods that are performed in microbiology as an adjunct to blood cultures
* Discuss the imperatives and needs for rapid repo... |
 |
Prophylaxis in Hemophilia: Do Immunologic Danger Signals or Pharmacokinetics Hold Relevance?
Provided by: Blood CME Center
Pediatric hematologist Donald L. Yee, MD, offers his expert opinion on the role of prophylaxis in the management of hemophilia patients, with a focus on inhibitor risk. In explicating data from clinical studies comparing prophylaxis with on-demand treatment, Dr. Yee draws on current danger signal theories that advance the argument that low-dose pro... |
 |
Clinical Overview of Hemophilia
Provided by: SolutionSight, Inc.
To provide a general overview and understanding of the fundamentals of hemophilia, including:
An explanation of normal coagulation and the defect in patients with hemophilia. The history, incidence and inheritance patterns of the disease
Program Learning Objectives:
1. Identify the normal coagulation process and the defect causing hemophi... |
 |
|
|